By Jason Douglas
Of DOW JONES NEWSWIRES
LONDON (Dow Jones)
Shire said it received a subpoena Sept. 23 from the U.S. Department of Health and Human Services Office of Inspector General in coordination with the U.S. Attorney for the Eastern District of Pennsylvania, seeking production of documents related to the sales and marketing of Adderall XR, Daytrana and Vyvanse.
Shire is cooperating and responding to this subpoena, it said.
Company Web site: www.shire.com
-By Jason Douglas, Dow Jones Newswires; 44-20-7842-9272; jason.douglas@dowjones.com